Candel Therapeutics, Inc.
CADL
$4.91
-$0.13-2.58%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -29.50M | -11.27M | -4.80M | 7.38M | -14.07M |
| Total Depreciation and Amortization | 163.00K | 195.00K | 242.00K | 245.00K | 245.00K |
| Total Amortization of Deferred Charges | 263.00K | 21.00K | 32.00K | 44.00K | 52.00K |
| Total Other Non-Cash Items | 14.91M | 461.00K | -4.44M | -14.46M | 7.22M |
| Change in Net Operating Assets | 3.60M | 356.00K | 67.00K | -1.83M | 743.00K |
| Cash from Operations | -10.57M | -10.24M | -8.89M | -8.62M | -5.81M |
| Capital Expenditure | -409.00K | -144.00K | -31.00K | -3.00K | -3.00K |
| Sale of Property, Plant, and Equipment | 0.00 | 27.00K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -409.00K | -117.00K | -31.00K | -3.00K | -3.00K |
| Total Debt Issued | 47.95M | -- | -- | -- | -- |
| Total Debt Repaid | -4.23M | -2.50M | -2.50M | -2.50M | -2.50M |
| Issuance of Common Stock | 4.00K | -- | 19.94M | 630.00K | 94.41M |
| Repurchase of Common Stock | -- | -693.00K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 178.00K | -178.00K | -- | -- | -- |
| Cash from Financing | 43.90M | -3.37M | 17.44M | -1.87M | 91.91M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 32.92M | -13.72M | 8.52M | -10.49M | 86.10M |